beta
LOXO
Loxo Oncology Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Loxo Oncology Inc is a biopharmaceutical company. It is engaged in the development of selective medicines for patients with genetically defined cancers.
Market Cap: 3.04 Billion
Primary Exchange: NASDAQ Global Market
Website: http://www.loxooncology.com
Shares Outstanding: 29.9 Million
Float: 29.5 Million
Dividend: 0.0 (0.0%)
Beta: 2.535371
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 627 trading days
From: 2019-02-05 To: 2019-02-15
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|